About the Authors

Dipak Kotecha

d.kotecha@bham.ac.uk

Affiliations Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, United Kingdom, University Hospitals Birmingham NHS Trust, Birmingham, United Kingdom

Amar Ahmed

Affiliation Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom

Melanie Calvert

Affiliation Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom

Mauro Lencioni

Affiliation University Hospitals Birmingham NHS Trust, Birmingham, United Kingdom

Caroline B. Terwee

Affiliation Department of Epidemiology and Biostatistics and the EMGO Institute of Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands

Deirdre A. Lane

Affiliations Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, United Kingdom

Competing Interests

All authors have completed the ICMJE uniform disclosure form (www.icmje.org/coi_disclosure.pdf) and declare the following, all outside of the submitted work: DK is the lead for the Beta-blockers in Heart Failure Collaborative Group (BB-meta-HF) and the RATE-AF trial, and has received honoraria and research grants from Menarini, professional development support from Daiichi-Sankyo and speaker fees from AtriCure; AA none; MC has received personal fees from Astellas Pharma outside the submitted work, and has received travel awards from the European Society of Cardiology and the Atrial Fibrillation NETwork (AFNET) to attend conferences presenting on the use of PROMs in cardiovascular research and clinical practice; ML has received travel grants from Pfizer, Bayer and Biosense Webster and has been on the speaker bureau for Bayer and Pfizer; CT has not received any funding but is one of the founders of the COSMIN initiative; DAL has received investigator-initiated educational grants from Bayer Healthcare, Bristol Myers Squibb (BMS) and Boehringer Ingelheim, has been on the speaker bureau for Boehringer Ingelheim, Bayer, and BMS/Pfizer and is a consultant for BMS and Boehringer Ingelheim.

Author Contributions

Conceptualization: DK. Data curation: AA DAL DK. Formal analysis: AA DAL DK. Funding acquisition: DK. Investigation: AA DAL. Methodology: CT. Project administration: DK. Resources: DAL DK. Supervision: DAL DK. Validation: AA DAL DK. Visualization: DK. Writing – original draft: AA DAL DK. Writing – review & editing: MC ML CT DK.